Respiratory Diseases Drugs Market Global Briefing 2019

Respiratory Diseases Drugs Market Global Briefing 2019 Including: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations Covering: GlaxosmithKline; Astrazeneca; Teva Pharmaceuticals; Novartis AG; Boehringer Ingelheim GmbH

North America was the largest region in the respiratory diseases drugs market worth $32.1 billion in 2018, accounting for 56.7% of the global respiratory diseases drugs market, followed by Western Europe at 19.9% and Asia Pacific at 14.5% respectively.

Respiratory Diseases Drugs Global Market Briefing 2019 provides strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs sector.

Reasons to Purchase

  • Fully updated for 2019.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Respiratory Diseases Drugs Global Market Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the respiratory diseases drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the respiratory diseases drugs market and suggests approaches.

Scope

Markets Covered: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

Companies Mentioned: GlaxosmithKline; Astrazeneca; Teva Pharmaceuticals; Novartis AG; Boehringer Ingelheim GmbH

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Respiratory Diseases Drugs Market Characteristics
Respiratory Diseases Drugs Market Trends And Strategies
Growing Demand For Tamper-Resistant Pseudoephedrine (PSE) Products
Resurgence Of Nasal Remedies For Treatment Of Cold
Collaborations In The Respiratory Diseases Drugs Market
Increasing Demand For Personalized Medicines
Demand For Aerosol Respiratory Drugs
Use Of Biomarker For Precision Medicine
Rise Of Generic Respiratory Drugs
Respiratory Diseases Drugs Market Historic Growth
Respiratory Diseases Drugs Market Forecast Growth
Respiratory Diseases Drugs Market Segmentation
Global Respiratory Diseases Drugs Market, Split By Segment, 2018, $ Billion
Anti-Asthmatics And COPD Drugs
Cough And Cold Preparations
Global Respiratory Diseases Drugs Market, Historic And Forecast, Split By Segment, 2014-2022
Respiratory Diseases Drugs Market Geography Regional Comparison
Global Respiratory Diseases Drugs Market, Split By Region, 2018, $ Billion
Global Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022
Asia Pacific Respiratory Diseases Drugs Market Analysis
Asia Pacific Respiratory Diseases Drugs Market, 2014 – 2022
Asia Pacific Respiratory Diseases Drugs Market, Split By Country, 2018
Asia Pacific Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Asia Pacific Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
North America Respiratory Diseases Drugs Market Analysis
North America Respiratory Diseases Drugs Market, 2014 – 2022
North America Respiratory Diseases Drugs Market, Split By Country, 2018
North America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
North America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
Western Europe Respiratory Diseases Drugs Market Analysis
Western Europe Respiratory Diseases Drugs Market, 2014 – 2022
Western Europe Respiratory Diseases Drugs Market, Split By Country, 2018
Western Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Western Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
Eastern Europe Respiratory Diseases Drugs Market Analysis
Eastern Europe Respiratory Diseases Drugs Market, 2014 – 2022
Eastern Europe Respiratory Diseases Drugs Market, Split By Country, 2018
Eastern Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Eastern Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
South America Respiratory Diseases Drugs Market Analysis
South America Respiratory Diseases Drugs Market, 2014 – 2022
South America Respiratory Diseases Drugs Market, Split By Country, 2018
South America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
South America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
Africa Respiratory Diseases Drugs Market Analysis
Africa Respiratory Diseases Drugs Market, 2014 – 2022
Africa Respiratory Diseases Drugs Market, Split By Country, 2018
Africa Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Africa Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
Middle East Respiratory Diseases Drugs Market Analysis
Middle East Respiratory Diseases Drugs Market, 2014 – 2022
Middle East Respiratory Diseases Drugs Market, Split By Country, 2018
Middle East Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 – 2022
Middle East Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018
Respiratory Diseases Drugs Market Competitive Landscape
GlaxosmithKline
Astrazeneca
Teva Pharmaceuticals
Novartis AG
Boehringer Ingelheim GmbH
Respiratory Diseases Drugs Market, Key Mergers And Acquisitions
Mylan Acquired Stake In Meda
AstraZeneca Acquired Almirall’s Respiratory Business
Recordati Acquired Italchimici S.p.A.
Mast Therapeutics, Inc. Merged With Savara
Vectura Merged With Skyepharma
Ruthigen Merged With Pulmatrix
Ario Pharma Acquired PharmEste’s TRPA1 Research Assets
Appendix
Market Data Sources
NAICS Definitions Of Industry Covered In This Report
Research Methodology
Abbreviations
Currencies
Research Inquiries
The Business Research Company
Copyright And Disclaimer
List of Tables
Table 1: Global Respiratory Diseases Drugs Market, Historic Market Size, 2014-2018, $ Billion 12
Table 2: Global Respiratory Diseases Drugs Market, Forecast Market Size, 2018-2022, $ Billion 13
Table 3: Global Respiratory Diseases Drugs Market, Split By Segment, 2018, $ Billion 14
Table 4: Global Respiratory Diseases Drugs Market, Historic And Forecast, Split By Segment, 2014-2022 15
Table 5: Global Respiratory Diseases Drugs Market, Split By Region, 2018, $ Billion 17
Table 6: Global Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022 19
Table 7: Asia Pacific Respiratory Diseases Drugs Market, 2014-2022, $ Billion 21
Table 8: Asia Pacific Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 23
Table 9: Asia Pacific Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 25
Table 10: Asia Pacific Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 27
Table 11: North America Respiratory Diseases Drugs Market, 2014-2022, $ Billion 29
Table 12: North America Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 30
Table 13: North America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 32
Table 14: North America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 33
Table 15: Western Europe Respiratory Diseases Drugs Market, 2014-2022, $ Billion 35
Table 16: Western Europe Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 37
Table 17: Western Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 39
Table 18: Western Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 41
Table 19: Eastern Europe Respiratory Diseases Drugs Market, 2014-2022, $ Billion 43
Table 20: Eastern Europe Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 45
Table 21: Eastern Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 47
Table 22: Eastern Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 48
Table 23: South America Respiratory Diseases Drugs Market, 2014-2022, $ Billion 50
Table 24: South America Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 52
Table 25: South America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 54
Table 26: South America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 55
Table 27: Africa Respiratory Diseases Drugs Market, 2014-2022, $ Billion 56
Table 28: Africa Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 57
Table 29: Africa Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 59
Table 30: Africa Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 60
Table 31: Middle East Respiratory Diseases Drugs Market, 2014-2022, $ Billion 62
Table 32: Middle East Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 64
Table 33: Middle East Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014-2022 66
Table 34: Middle East Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 67
Table 35: Global Respiratory Diseases Drugs Market, Key Competitors Estimated Market Shares, 2018, Percentage (%) 69
Table 36: Respiratory Diseases Drugs Market Data Sources 75
List of Figures
Figure 1: Global Respiratory Diseases Drugs Market, Historic Market Size, 2014-2018, $ Billion 12
Figure 2: Global Respiratory Diseases Drugs Market, Forecast Market Size, 2018-2022, $ Billion 13
Figure 3: Global Respiratory Diseases Drugs Market, Split By Segment, 2018, $ Billion 14
Figure 4: Global Respiratory Diseases Drugs Market, Historic And Forecast, Split By Segment, 2014-2022 15
Figure 5: Global Respiratory Diseases Drugs Market, Split By Region, 2018, $ Billion 16
Figure 6: Global Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2014-2022 18
Figure 7: Asia Pacific Respiratory Diseases Drugs Market, 2014-2022, $ Billion 20
Figure 8: Asia Pacific Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 22
Figure 9: Asia Pacific Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 24
Figure 10: Asia Pacific Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 26
Figure 11: North America Respiratory Diseases Drugs Market, 2014-2022, $ Billion 28
Figure 12: North America Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 30
Figure 13: North America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 31
Figure 14: North America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 33
Figure 15: Western Europe Respiratory Diseases Drugs Market, 2014-2022, $ Billion 34
Figure 16: Western Europe Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 36
Figure 17: Western Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 38
Figure 18: Western Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 40
Figure 19: Eastern Europe Respiratory Diseases Drugs Market, 2014-2022, $ Billion 42
Figure 20: Eastern Europe Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 44
Figure 21: Eastern Europe Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 46
Figure 22: Eastern Europe Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 48
Figure 23: South America Respiratory Diseases Drugs Market, 2014-2022, $ Billion 49
Figure 24: South America Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 51
Figure 25: South America Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 53
Figure 26: South America Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 55
Figure 27: Africa Respiratory Diseases Drugs Market, 2014-2022, $ Billion 56
Figure 28: Africa Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 57
Figure 29: Africa Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 58
Figure 30: Africa Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 60
Figure 31: Middle East Respiratory Diseases Drugs Market, 2014-2022, $ Billion 61
Figure 32: Middle East Respiratory Diseases Drugs Market, Split By Country, 2018, $ Billion 63
Figure 33: Middle East Respiratory Diseases Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2014 - 2022 65
Figure 34: Middle East Respiratory Diseases Drugs Market, Per Capita Average Expenditure, By Country, 2018 67
Figure 35: Global Respiratory Diseases Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%) 68

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook